Cell Therapeutics for Treating Stroke

The present invention relates to a cell therapeutic agent for treating stroke comprising embryonic stem cell-derived mesenchymal stem cells as an active component. According to the present invention, in case of concurrent administration of embryonic stem cell-derived mesenchymal stem cells and EPO t...

Full description

Saved in:
Bibliographic Details
Main Authors CHOI JEEIN, CHOI MI KYUNG, CHOI SUNG HYUN, KIM MINYOUNG, KIM KI NAM
Format Patent
LanguageEnglish
Korean
Published 01.04.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a cell therapeutic agent for treating stroke comprising embryonic stem cell-derived mesenchymal stem cells as an active component. According to the present invention, in case of concurrent administration of embryonic stem cell-derived mesenchymal stem cells and EPO to stroke patients, it is expected to recover brain nerve damage and effectively improve behavioral disorders caused by stroke. 본 발명은 배아줄기세포 유래 중간엽 줄기세포를 유효성분으로 포함하는 뇌졸중 치료용 세포치료제에 관한 것으로, 본 발명에 따라, 뇌졸중 환자에게 배아줄기세포 유래 중간엽 줄기세포 및 EPO를 병용 투여하는 경우, 뇌 신경 손상을 회복시키고, 뇌졸중에 의한 행동장애의 효과적인 개선을 기대할 수 있다.
Bibliography:Application Number: KR20200124348